As both p18INK4c and BLIMP-1 induce a post-mitotic state, it is not surprising that they have both been identified as tumour suppressor proteins that are commonly compromised by mutation or silencing in B cell lymphoma—including EBV-negative DLBCL [56–59]. The gene discussed is PRDM1; the disease is B-cell non-Hodgkin lymphoma.